UniProt Q8IL11
M17 leucyl aminopeptidase (Q8IL11)
M17 leucyl aminopeptidase (UniProt Q8IL11), EC 3.4.11.1: 20 experimental structures on GenesisL1, 6 ligands bound, 20 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q8IL11
- Protein
- M17 leucyl aminopeptidase
- EC
- 3.4.11.1
- Experimental structures
- 20
- Predicted models
- 0
- Ligands
- 6
- Pockets
- 20 · 1 record with a druggable one
Structures
20 records of Q8IL11 in the MolNFT archive: 20 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3KQX | Structure of a protease 1 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KQX | Structure of a protease 1 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KQZ | Structure of a protease 2 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KQZ | Structure of a protease 2 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KR4 | Structure of a protease 3 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KR4 | Structure of a protease 3 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KR5 | Structure of a protease 4 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3KR5 | Structure of a protease 4 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3T8W | A bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 3T8W | A bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4K3N | Phosphonic Arginine Mimetics as Inhibitors of the M17 Aminopeptidases from Plasmodium falciparum | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4K3N | Phosphonic arginine mimetics as inhibitors of the M17 aminopeptidases from plasmodium falciparum | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4R6T | Structure of the m17 leucyl aminopeptidase from malaria complexed with a hydroxamic acid-based… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4R6T | Structure of the M17 leucyl aminopeptidase from malaria complexed with a hydroxamic acid-based… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4R7M | Structure of the m17 leucyl aminopeptidase from malaria complexed with a hydroxamic acid-based… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4R7M | Structure of the M17 leucyl aminopeptidase from malaria complexed with a hydroxamic acid-based… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 4X2T | X-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 7RIE | Plasmodium falciparum M17 in complex with inhibitor MIPS2571 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | CO3, ZN, 5IF, SO4 | 20 (best 0.77) |
| 7SRV | Metal dependent activation of plasmodium falciparum M17 aminopeptidase (inactive form), spacegroup… | x-ray diffraction | A, B, C, D, E, F | ZN, CO3, CA, PO4 | — |
| 7T3V | Metal dependent activation of plasmodium falciparum M17 aminopeptidase, spacegroup P22121 after… | x-ray diffraction | A, B, C, D, E, F | CO3, ZN, SO4 | — |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.